HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Response of a KIT-positive extra-abdominal fibromatosis to imatinib mesylate and KIT genetic analysis.

AuthorsAnthony Gonçalves, Genevieve Monges, Ying Yang, Fabienne Palmerini, Patrice Dubreuil, Tetsuro Noguchi, Jocelyne Jacquemier, Donatella Di Stefano, Jean-Robert Delpero, Hagay Sobol, Francois Bertucci
JournalJournal of the National Cancer Institute (J Natl Cancer Inst) Vol. 98 Issue 8 Pg. 562-3 (Apr 19 2006) ISSN: 1460-2105 [Electronic] United States
PMID16622127 (Publication Type: Case Reports, Letter)
Chemical References
  • Antineoplastic Agents
  • Benzamides
  • Biomarkers, Tumor
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Imatinib Mesylate
  • Protein-Tyrosine Kinases
  • Proto-Oncogene Proteins c-kit
  • Receptor, Platelet-Derived Growth Factor alpha
Topics
  • Adult
  • Antineoplastic Agents (therapeutic use)
  • Benzamides
  • Biomarkers, Tumor (analysis, genetics)
  • Female
  • Fibroma (chemistry)
  • Germ-Line Mutation
  • Humans
  • Imatinib Mesylate
  • Piperazines (therapeutic use)
  • Protein Kinase Inhibitors (therapeutic use)
  • Protein-Tyrosine Kinases (antagonists & inhibitors)
  • Proto-Oncogene Proteins c-kit (analysis, genetics)
  • Pyrimidines (therapeutic use)
  • Receptor, Platelet-Derived Growth Factor alpha (analysis, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: